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INTRODUCTION
PCRs have revolutionised the detection 
of bacteria in clinical samples since their 
widespread introduction in the 1990s.1 
Quantitative PCR (qPCR), also known 
as specific PCR, involves the targeting 
of particular bacterial species. The tech-
nique uses specific primers (short strands 
of nucleic acid needed to initiate DNA 
replication) and fluorescent probes to 
allow real-time quantification of target 
bacterial DNA during amplification. The 
qPCR assay is a mainstay of microbio-
logical diagnostics within the National 
Health Service (NHS). At our hospital 
approximately 200 qPCRs are performed 
per week for the investigation of bacte-
rial infections. Although qPCR is by far 
the most frequently used molecular tech-
nique in bacterial diagnostics, in certain 
scenarios a broad-range (non-specific) 
16S rDNA (ribosomal DNA) PCR is 
increasingly being used. Broad-range 
16S rDNA PCR is also more commonly 
used in research settings, originally for 
use in detecting and identifying unusual 
bacterial species but now more widely 
used in the rapidly expanding field of 
microbiome research. This technique 
provides the initial step in the process of 
analysing complex microbial communities 
in human, zoological and even geological 
settings. In the future, analysis of indi-
vidualised microbial communities using 
broad-range 16S rDNA PCR may be a key 
component of personalised medicine.
QUANTITATIVE OR SPECIFIC PCR
The two major benefits that qPCR offers 
over traditional culture methods are 
described below and in table 1.
Speed
Bacterial culture takes at least 24–48 hours 
for determination of a positive result, or 
longer for slow-growing organisms such 
as Mycobacterium tuberculosis.2 Further-
more, some fastidious organisms may 
commonly escape detection in routine 
cultures, for example, Kingella kingae.3 
In qPCR, the use of fluorescent probes 
enables bacterial load to be detected and 
quantified in real time, hence reducing 
time to diagnosis and correct treatment 
initiation.4 The fluorescence is measured 
during the assay, and when it reaches a 
prespecified level the assay is considered 
positive. The number of cycles taken to 
reach this threshold is known as the cycle 
threshold value (CT value) and is propor-
tional to the initial quantity of DNA 
present in the sample: that is, the lower 
the CT value, the higher the initial quan-
tity of DNA (figure 1A). Strong positive 
results will be in the high teens or early 
20s, whereas a sample with a CT value 
of 38–40 will be considered only border-
line positive. Monitoring of the CT value 
can be used to assess therapeutic efficacy, 
for example, in tuberculosis.5
Utility despite prior antibiotic use
Culture only enables the detection of 
living organisms, and is therefore suscep-
tible to false-negative results. qPCR 
will detect bacterial DNA regardless of 
viability, which is advantageous in a clin-
ical context when empiric antibiotics may 
have already been given.6 7 This benefit 
also applies to broad-range 16S rDNA 
PCR (see below and table 1).
BROAD-RANGE 16S RDNA PCR
Unexpected or unusual pathogens may 
be missed if qPCR primers target only 
one bacterial species/family and qPCR 
testing panels may be necessary for diag-
nosis.8 Even with a large panel of qPCR 
assays, you will still only find what you 
set out to look for. Using a broad-range 
16S rDNA PCR can address this issue. 
Primers are used that target the highly 
conserved regions of the 16S ribosomal 
subunit, present in all bacterial ribosomal 
genes (rDNA) (figure 1B). These subunits 
also consist of variable regions that differ 
between bacterial genera and species. 
Using broad-range 16S rDNA PCR, 
followed by DNA sequencing, allows the 
amplification and identification of any 
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bacterial DNA present in a clinical sample.8 9 After 
sequencing, the sequences are compared with known 
nucleotide sequences on databases such as GenBank to 
identify the bacteria.8 10
INDICATIONS OF BROAD-RANGE 16S RDNA PCR
Broad-range 16S rDNA PCR can detect both viable 
and non-viable bacteria, similar to qPCR. It is also 
clinically useful when other techniques give negative 
results, for example, in culture-negative endocarditis, 
septic arthritis, meningitis or long-line infections.8 11 
The bacteria identified are often unusual, rare, diffi-
cult to culture, or bacteria for which a specific PCR is 
not available.8 9 Examples include the identification of 
Helicobacter sp as the underlying cause of osteomy-
elitis or Neisseria meningitidis as the unexpected cause 
of septic arthritis by broad-range 16S rDNA PCR, after 
negative results were produced from other microbial 
diagnostic techniques.12 13
It is also possible to make distinctions between 
species: Ureaplasma spp consist of two bacterial strains, 
Ureaplasma parvum and Ureaplasma urealyticum, indis-
tinguishable by culture, and each suspected to cause 
different pathology in neonates.7 14 15 Broad-range 16S 
rDNA PCR, followed by sequencing, has allowed the 
differentiation and identification of both species, aiding 
research into species-specific pathogenicity.8 16
Additionally, broad-range 16S rDNA PCR may iden-
tify previously uncharacterised bacteria. Broad-range 
16S rDNA PCR enabled the identification of Barton-
ella henselae and Tropheryma whippelii as the patho-
gens underlying catscratch disease and Whipple’s 
disease, respectively.17 18
However, the breadth of broad-range 16S rDNA 
PCR renders it vulnerable to contamination. All bacte-
rial DNA present in a sample is amplified, including 
that which is unavoidably present in reagents, meaning 
low-level environmental contamination is impossible to 
eliminate entirely. At a high number of thermal cycles, 
this low-level background contaminant DNA will be 
amplified and give a false-positive result. To reduce 
this risk, sequencing must be carried out to distinguish 
between a genuine pathogen and contaminants (often 
waterborne bacteria highly unlikely to cause disease). 
Using standard sequencing techniques, only the most 
dominant DNA sequence can be identified, which 
means that in samples where more than one bacterial 
species is present (such as stool) results are uninterpre-
table. This means broad-range 16S rDNA PCR with 
standard sequencing is not useful for samples from 
non-sterile sites.
To further reduce the risk of being overwhelmed 
by contamination, the number of thermal cycles is 
reduced compared with specific qPCRs, but this has 
the concomitant effect of reducing sensitivity.19 This 
means that broad-range 16S rDNA PCR will always 
be less sensitive than a well-designed specific qPCR 
to the order of 1–2 logs. A final disadvantage is that 
these methods may be limited to research or specialist 
laboratories, meaning samples may need to be sent 
away, increasing the turnaround time.16 A comparison 
of the key benefits and disadvantages between culture 
methods, qPCR and broad-range 16S rDNA PCR is 
shown in table 1, and a flowchart of suggested inves-
tigations for suspected bacterial sterile site infections 
incorporating both qPCR and broad-range 16S rDNA 
PCR is seen in figure 1C.
In summary, broad-range 16S rDNA PCR is a crucial 
adjunct to microbiological diagnostics as a second line 
when infection of a sterile site is highly suspected, but 
culture and qPCR for the most likely pathogens have 
been proven negative. Owing to the risk of detecting 
bacterial DNA contamination, fewer PCR cycles are 
performed than for qPCRs, resulting in a less sensi-
tive assay, so qPCRs should be used first (figure 1C). 
In research, 16S rDNA PCR will continue to be 
used to identify novel bacterial species, characterise 
species-specific pathogenicity and as a gold-standard 
assay to compare against when evaluating new assays. 
It is also used in combination with cutting-edge tech-
niques, such as next-generation sequencing. This is 
used to characterise complex microbial populations 
in the gut, stool, vagina, placenta, lung and in envi-
ronmental settings.20 As next-generation sequencing 
based on broad-range 16S rDNA PCR becomes more 
affordable and widely available, these techniques 
Table 1 Comparison of advantages and disadvantages of culture methods, qPCR and 16S rDNA PCR
Method Advantages Disadvantages
Culture  ► Widely available
 ► Inexpensive
 ► Antimicrobial susceptibility data
 ► Slower
 ► Not species-specific
 ► Only detects living organisms
 ► Cannot identify all bacteria
qPCR  ► Fastest method
 ► Detects viable and non-viable bacteria
 ► Low chance of contamination
 ► High sensitivity
 ► Narrow spectrum (species-specific)
 ► Limited antimicrobial susceptibility data
16S rDNA PCR  ► Detects viable and non-viable bacteria
 ► Wide spectrum
 ► Allows species differentiation (with sequencing)
 ► Second-line option for undetectable bacteria
 ► Vulnerable to contamination
 ► Slower than qPCR
 ► No antimicrobial susceptibility data
qPCR, quantitative PCR.
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have the potential to allow tailored therapy as our 
understanding of the complex interaction between 
ourselves and our microbial communities increases.21 
For example, broad-range 16S rDNA PCR of micro-
bial gut communities has identified distinct changes 
in conditions such as HIV, post preterm delivery of 
neonates and malnutrition.22–24 As we explore the 
potential therapeutic avenues revealed in these diverse 
conditions, it is likely that broad-range 16S rDNA 
PCR will be a cornerstone of further research.
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Figure 1 (A) The result of a qPCR assay comparing fluorescence with cycle number. The results for multiple serial dilutions are presented 
demonstrating the cycle threshold value for each sample. The highest concentration sample (a) crosses the cycle threshold between cycles 20 
and 21. The lowest concentration sample (b) crosses the cycle threshold at cycle 41. (B) Schema of 16S rRNA gene demonstrating variable 
(different between bacterial genera and species) and conserved regions (present in all bacterial rDNA) with placement of primers at conserved 
regions. After PCR amplification, the variable regions (V5–V7) are then sequenced to identify the bacteria present. (C) Flowchart demonstrating 
clinical guidance for the use of culture methods, qPCR and broad-range 16S rDNA PCR for sterile site infections where a bacterial cause is 
suspected. qPCR:quantitative PCR.
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